REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Dr.Max 182 S.R.O. (Slovakia)

Main Activities: Pharmacies and Drug Stores | Department Stores
Full name: Dr.Max 182 S.R.O. Profile Updated: July 30, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Dr.Max 182 S.R.O. is an enterprise located in Slovakia, with the main office in Kosice. The company operates in the Pharmacies and Drug Stores sector. It was incorporated on April 07, 2020. Dr.Max 182 S.R.O. currently employs 5 - 9 (2025) people. From the latest financial highlights, Dr.Max 182 S.R.O. reported a net sales revenue increase of 38.43% in 2024. Over the same period, its total assets grew by 1.23%. The net profit margin of Dr.Max 182 S.R.O. decreased by 3.12% in 2024.

Headquarters
Moldavska cesta, 8/A
Kosice; Kosicky; Postal Code: 04011

Contact Details: Purchase the Dr.Max 182 S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Dr.Max 182 S.R.O. report to view the information.
Registered Capital:
Purchase the Dr.Max 182 S.R.O. report to view the information.
Financial Auditors:
Purchase the Dr.Max 182 S.R.O. report to view the information.
Incorporation Date:
April 07, 2020
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Dr.Max 182 S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
38.43%▲
Total operating revenue
35.29%▲
Operating profit (EBIT)
-40.84%▼
EBITDA
-29.15%▼
Net Profit (Loss) for the Period
-60.89%▼
Total Assets
1.23%▲
Total Equity
19.36%▲
Operating Profit Margin (ROS)
-2.63%▼
Net Profit Margin
-3.12%▼
Return on Equity (ROE)
-33.29%▼
Debt/Equity
-0.87%▼
Quick Ratio
0.07%▲
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo